Company · CIK 0001389072 · SIC 3841 — Surgical & Medical Instruments & Apparatus
HeartWare International, Inc. · HTWR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2015 MForm 4 → | May 13, 5:08 pm EDT | Robert Bernard StockmanDirector | 250 | — | — | 17,010 | — | plan? |
| May 12, 2015 MForm 4 → | May 13, 5:07 pm EDT | C Raymond Larkin Jr.Director | 250 | — | — | 6,500 | — | plan? |
| May 12, 2015 MForm 4 → | May 13, 5:07 pm EDT | Seth Loring HarrisonDirector | 250 | — | — | 134,893 | — | plan? |
| May 12, 2015 MForm 4 → | May 13, 5:06 pm EDT | Timothy J BarberichDirector | 250 | — | — | 9,607 | — | plan? |
| May 1, 2015 MForm 4 → | May 4, 5:06 pm EDT | Denis Newell WadeDirector | 1,500 | — | — | 4,000 | — | plan? |
| May 1, 2015 MForm 4 → | May 4, 5:05 pm EDT | Robert Bain ThomasDirector | 1,500 | — | — | 2,760 | — | plan? |
| May 1, 2015 MForm 4 → | May 4, 5:04 pm EDT | Robert Bernard StockmanDirector | 1,500 | — | — | 16,760 | — | plan? |
| May 1, 2015 MForm 4 → | May 4, 5:04 pm EDT | C Raymond Larkin Jr.Director | 1,500 | — | — | 6,250 | — | plan? |
| May 1, 2015 MForm 4 → | May 4, 5:03 pm EDT | Seth Loring HarrisonDirector | 1,500 | — | — | 134,643 | — | plan? |
| May 1, 2015 MForm 4 → | May 4, 5:02 pm EDT | Cynthia L FeldmannDirector | 1,750 | — | — | 3,000 | — | plan? |
| May 1, 2015 MForm 4 → | May 4, 5:01 pm EDT | Timothy J BarberichDirector | 1,500 | — | — | 9,357 | — | plan? |
| Apr 17, 2015 SForm 4 → | Apr 21, 5:29 pm EDT | ADAGE CAPITAL PARTNERS GP LLC +410% Owner | 173,267 | $80.70 | $13,982,323 | 1,832,969 | −8.64% | plan? |
| Apr 1, 2015 SForm 4 → | Apr 2, 5:07 pm EDT | James SchuermannSVP, Sales & Marketing | 1,000 | $86.34 | $86,339 | 11,980 | −7.70% | plan? |
| Mar 30, 2015 SForm 4 → | Mar 30, 5:14 pm EDT | Lawrence J KnopfGeneral Counsel | 1,741 | $88.81 | $154,619 | 14,632 | −10.6% | plan? |
| Mar 28, 2015 MForm 4 → | Mar 30, 5:14 pm EDT | Lawrence J KnopfGeneral Counsel | 5,250 | — | — | 16,373 | — | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 8:24 pm EST | Robert E YocherSVP Regulatory Affairs | 210 | $89.53 | $18,801 | 7,500 | −2.72% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 8:23 pm EST | Mark StrongSenior VP, R&D and Quality | 395 | $89.56 | $35,376 | 1,007 | −28.2% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 8:22 pm EST | James SchuermannSVP, Sales & Marketing | 574 | $89.56 | $51,407 | 12,980 | −4.23% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 8:21 pm EST | Peter F McAreeSVP, CFO and Treasurer | 464 | $89.53 | $41,542 | 10,921 | −4.08% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 8:20 pm EST | Jeffrey LaRoseChief Scientific Officer | 337 | $89.92 | $30,303 | 6,897 | −4.66% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 8:19 pm EST | Lawrence J KnopfGeneral Counsel | 399 | $89.52 | $35,718 | 11,123 | −3.46% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 8:18 pm EST | Douglas Evan GodshallPresident & Chief Exec Officer, Director | 1,842 | $89.58 | $165,006 | 70,670 | −2.54% | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:24 pm EST | Robert E YocherSVP Regulatory Affairs | 632 | — | — | 7,710 | — | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:23 pm EST | Mark StrongSenior VP, R&D and Quality | 527 | — | — | 1,402 | — | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:22 pm EST | James SchuermannSVP, Sales & Marketing | 1,712 | — | — | 13,554 | — | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:21 pm EST | Peter F McAreeSVP, CFO and Treasurer | 1,394 | — | — | 11,385 | — | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:20 pm EST | Jeffrey LaRoseChief Scientific Officer | 1,200 | — | — | 7,234 | — | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:19 pm EST | Lawrence J KnopfGeneral Counsel | 1,200 | — | — | 11,522 | — | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:18 pm EST | Douglas Evan GodshallPresident & Chief Exec Officer, Director | 5,500 | — | — | 72,512 | — | plan? |
| Feb 9, 2015 SForm 4 → | Feb 10, 5:06 pm EST | Robert E YocherSVP Regulatory Affairs | 309 | $86.68 | $26,783 | 7,078 | −4.18% | plan? |
| Feb 9, 2015 SForm 4 → | Feb 10, 5:06 pm EST | James SchuermannSVP, Sales & Marketing | 523 | $86.45 | $45,213 | 11,842 | −4.23% | plan? |
| Feb 9, 2015 SForm 4 → | Feb 10, 5:05 pm EST | Peter F McAreeSVP, CFO and Treasurer | 510 | $86.68 | $44,205 | 9,991 | −4.86% | plan? |
| Feb 9, 2015 SForm 4 → | Feb 10, 5:04 pm EST | Jeffrey LaRoseChief Scientific Officer | 491 | $86.46 | $42,452 | 6,034 | −7.52% | plan? |
| Feb 9, 2015 SForm 4 → | Feb 10, 5:03 pm EST | Lawrence J KnopfGeneral Counsel | 510 | $86.47 | $44,100 | 10,322 | −4.71% | plan? |
| Feb 9, 2015 SForm 4 → | Feb 10, 5:02 pm EST | Douglas Evan GodshallPresident & Chief Exec Officer, Director | 1,698 | $86.58 | $147,014 | 67,012 | −2.47% | plan? |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:06 pm EST | Robert E YocherSVP Regulatory Affairs | 800 | — | — | 7,387 | — | plan? |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:06 pm EST | James SchuermannSVP, Sales & Marketing | 1,600 | — | — | 12,365 | — | plan? |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:05 pm EST | Peter F McAreeSVP, CFO and Treasurer | 1,400 | — | — | 10,501 | — | plan? |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:04 pm EST | Jeffrey LaRoseChief Scientific Officer | 1,600 | — | — | 6,525 | — | plan? |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:03 pm EST | Lawrence J KnopfGeneral Counsel | 1,400 | — | — | 10,832 | — | plan? |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:02 pm EST | Douglas Evan GodshallPresident & Chief Exec Officer, Director | 5,000 | — | — | 68,710 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 5, 5:25 pm EST | James SchuermannSVP, Sales & Marketing | 1,429 | $72.69 | $103,869 | 10,765 | −11.7% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 5, 5:25 pm EST | James SchuermannSVP, Sales & Marketing | 1,429 | $21.42 | $30,609 | 12,194 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2015 MForm 4 → | Feb 26, 8:18 pm EST | Douglas Evan GodshallPresident & Chief Exec Officer, Director | 5,500 | — | — | 49,250 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 8:21 pm EST | Mark StrongSenior VP, R&D and Quality | 4,000 | — | — | 26,606 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 8:20 pm EST | James SchuermannSVP, Sales & Marketing | 3,500 | — | — | 17,713 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 8:19 pm EST | Peter F McAreeSVP, CFO and Treasurer | 3,500 | — | — | 24,375 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 8:18 pm EST | Katrin LeadleyChief Medical Officer | 3,500 | — | — | 18,500 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 8:17 pm EST | Jeffrey LaRoseChief Scientific Officer | 3,000 | — | — | 15,375 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 8:16 pm EST | Lawrence J KnopfGeneral Counsel | 3,500 | — | — | 17,850 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 8:14 pm EST | Douglas Evan GodshallPresident & Chief Exec Officer, Director | 13,750 | — | — | 54,750 | — | |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:06 pm EST | Robert E YocherSVP Regulatory Affairs | 800 | — | — | 7,627 | — | |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:06 pm EST | James SchuermannSVP, Sales & Marketing | 1,600 | — | — | 14,213 | — | |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:05 pm EST | Peter F McAreeSVP, CFO and Treasurer | 1,400 | — | — | 20,875 | — | |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:04 pm EST | Jeffrey LaRoseChief Scientific Officer | 1,600 | — | — | 12,375 | — | |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:03 pm EST | Lawrence J KnopfGeneral Counsel | 1,400 | — | — | 14,350 | — | |
| Feb 7, 2015 MForm 4 → | Feb 10, 5:02 pm EST | Douglas Evan GodshallPresident & Chief Exec Officer, Director | 5,000 | — | — | 41,000 | — | |
| Jan 2, 2015 MForm 4 → | Jan 5, 5:25 pm EST | James SchuermannSVP, Sales & Marketing | 1,429 | — | — | 0 | — |